Identification of a novel HIP1-ALK fusion variant in non-small-cell lung cancer (NSCLC) and discovery of ALK I1171 (I1171N/S) mutations in two ALK-rearranged NSCLC patients with resistance to Alectinib - Ou, S H; Klempner, S J; Greenbowe, J R (J Thorac Oncol, 2014)
, et al.